Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) fell 0.2% on Thursday . The company traded as low as $12.87 and last traded at $12.87. 121 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 2,743 shares. The stock had previously closed at $12.90.
Shionogi & Co., Ltd. Stock Performance
The stock’s 50-day moving average price is $27.98 and its 200-day moving average price is $38.12.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- 3 REITs to Buy and Hold for the Long Term
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Insider Trades May Not Tell You What You Think
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
